| Literature DB >> 25548790 |
Agda M Andreotti1, Marcelo C Goiato1, Eduardo P Pellizzer1, Aldiéris A Pesqueira1, Aimée M Guiotti1, Humberto Gennari-Filho1, Daniela M dos Santos1.
Abstract
The purpose of this literature review was to describe the main features of phantom eye syndrome in relation to their possible causes, symptoms, treatments, and influence of eye amputation on quality of life of anophthalmic patients. For this, a bibliographical research was performed in Pubmed database using the following terms: "eye amputation," "eye trauma," "phantom eye syndrome," "phantom pain," and "quality of life," associated or not. Thirteen studies were selected, besides some relevant references contained in the selected manuscripts and other studies hallowed in the literature. Thus, 56 articles were included in this review. The phantom eye syndrome is defined as any sensation reported by the patient with anophthalmia, originated anophthalmic cavity. In phantom eye syndrome, at least one of these three symptoms has to be present: phantom vision, phantom pain, and phantom sensations. This syndrome has a direct influence on the quality of life of the patients, and psychological support is recommended before and after the amputation of the eyeball as well as aid in the treatment of the syndrome. Therefore, it is suggested that, for more effective treatment of phantom eye syndrome, drug therapy should be associated with psychological approach.Entities:
Mesh:
Year: 2014 PMID: 25548790 PMCID: PMC4273592 DOI: 10.1155/2014/686493
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Inclusion and exclusion criteria for selection of articles.
| Inclusion criteria | Exclusion criteria |
|---|---|
| Articles in English | Articles in other languages |
|
| |
| Articles published between 2000 and 2012 | Articles not published from 2000 to 2012 |
|
| |
| Articles that report major cause of eye loss and indications for surgical removal | Articles that do not cite the phantom eye syndrome as a result of eye loss |
|
| |
| Articles that report the phantom eye syndrome as a result of eye loss | Articles that do not contain information about the phantom eye syndrome, as causes, characteristics, symptoms, and treatment |
|
| |
| Articles that report at least one of the following: causes, characteristics, symptoms, and treatment options for phantom eye syndrome | — |
|
| |
| Articles that report the influence of eye loss in quality of life | — |
Drugs used in the treatment of phantom phenomena.
| Pharmacological class | Drugs |
|---|---|
| Antidepressants | Amitriptylinex |
| Tricyclicsx | |
| Duloxetine | |
| Milnacipran | |
|
| |
| Anticonvulsants | Gabapentinx |
| Pregabalinx | |
| Carbamazepinex | |
| Oxcarbazepinex | |
|
| |
| Sodium channel blockers | Bupivacainex |
| Lidocaine | |
| Mexiletine | |
|
| |
| N-Methyl-D-aspartate receptor antagonists | Ketaminex |
| Memantinex | |
|
| |
| Opioids | Morphinex |
| Methadone | |
| Buprenorphinex | |
| Tramadolx | |
|
| |
| Others | Calcitoninx |
| Benzodiazepine | |
| Acetominophenx | |
| Nonsteroidal anti-inflammatoryx | |
| Beta blockersx | |
| Muscle relaxantsx | |
| Corticosteroidsx | |
| Neurolepticsx | |
| Barbituricsx | |
xDrugs with reports of improvements in the clinical aspect of the phantom phenomena.